$77.99
-0.11-0.14%
At close: -
$77.71
-0.28-0.36%
After Hours: Nov 29, 3:55 PM EDT
DexCom reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of DexCom using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-24 | $0.45 | $0.43 | 4.65 % |
Jun 2024 | 2024-07-25 | $0.43 | $0.39 | 10.3 % |
Mar 2024 | 2024-04-25 | $0.32 | $0.27 | 18.5 % |
Dec 2023 | 2024-02-08 | $0.50 | $0.43 | 16.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-24 | $994.20M | $990.71M | 0.35 % |
Jun 2024 | 2024-07-25 | $1.00B | $1.04B | -3.46 % |
Mar 2024 | 2024-04-25 | $921.00M | $909.24M | 1.29 % |
Dec 2023 | 2024-02-08 | $1.03B | $1.02B | 1.42 % |
DexCom (DXCM) is scheduled to report earnings on February 6, 2025. The last reported earnings were for reported on October 24, 2024 for Q3.
The Actual EPS was $0.45, which beat the estimate of $0.43.
The Actual Revenue was $994.2M, which beat the estimate of $990.7M.
Browse earnings estimates, EPS, and revenue on all stocks.